Different claims require different evidence
An association states that two measured features vary together. A mechanism proposes and tests an intervening biological process. Causation states that changing one factor changes another under defined conditions. Prediction concerns performance for a future or unseen outcome. Treatment effect concerns the consequence of an intervention in a target population.
These claims can inform one another, but none is a synonym for another. A plausible mechanism does not prove that it explains a human association. A predictive marker need not be causal. A causal factor need not be an effective or safe treatment target.
An evidence chain, not a mandatory ladder
A productive research sequence may move from observation to replication, temporal evidence, mechanistic plausibility, experimental investigation, human validation and intervention evidence. Not every question requires every step, and science rarely proceeds in a single direction.
Replication tests whether an observation persists across samples and methods. Longitudinal evidence clarifies temporal order. Experimental work tests whether controlled perturbation changes an outcome. Human validation determines whether a mechanism or marker retains meaning in the population of interest.
Triangulating barrier and gut–brain evidence
Barrier-related human associations, animal-model microbiome and behavioural results, transcriptomic patterns and longitudinal protocols represent different positions in this evidence chain. Together they can refine questions and expose inconsistencies.
They do not establish that intestinal permeability causes a mental-health or neurodevelopmental condition. The microbiota–gut–brain system is bidirectional, and confounding or reverse pathways may produce similar observations.
Claims should stop where the design stops
A protocol establishes planned methods, not results. A cross-sectional study establishes measured association, not temporal direction. An animal experiment supports conclusions within its model, not human clinical efficacy. Transcriptomics identifies expression patterns, not whole-organ function.
Scientific restraint is productive because it identifies the next discriminating study. Rather than weakening a finding, a precise boundary makes the evidence reusable and allows later work to change confidence transparently.
What the evidence supports
The combined verified record supports a programme spanning human evidence synthesis, longitudinal protocol development and controlled animal-model molecular, microbial and behavioural research.
It supports triangulation across designs while preserving the inferential boundary of each result.
What remains uncertain
The existing record does not establish that permeability causes mental-health or neurodevelopmental conditions or that modifying it produces human treatment benefit.
Mechanistic routes, predictive validity and intervention effects require separate, population-specific validation.
References
- Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015;28(2):203–209.
- Asbjornsdottir B, Snorradottir H, Andresdottir E, et al. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis. Nutrients 2020;12(7):1982. doi:10.3390/nu12071982. DOI
- Asbjornsdottir B, Sigurdsson S, Miranda-Ribera A, et al. Evaluating Prophylactic Effect of Bovine Colostrum on Intestinal Barrier Function in Zonulin Transgenic Mice: A Transcriptomic Study. International Journal of Molecular Sciences 2023;24(19):14730. doi:10.3390/ijms241914730. DOI